It is reported miR-155 promotes glycolysis and tricarboxylic acid (TCA) cycle mediated by the cMYC/pyruvate kinase M2 isoform (PKM2) axis by inhibiting FOXO3a, laying the foundation for the energy required for breast cancer development (Kim et al., 2018). Here, FOXO3 is linked to breast carcinoma.